FEATURED CONTRIBUTED CONTENT

Evidence Wisely: Advanced Learnings from the Field


Evidence Wisely: Advanced Learnings from the Field

In the ever-evolving healthcare landscape, stakeholders are demanding more Real-World Evidence (RWE), and more RWE is becoming available. That should mean that demand should be easy to satisfy, right? Explore this informative ebook to learn about the latest in RWE, using the ebook link below. There is also a related podcast, entitled, “The Real Value […]

May 31, 2017 More Clinical »
Want to catch up on everything from DIA 2017?


Want to catch up on everything from DIA 2017?

All the important discussions that took place were captured on Twitter. Find out what you missed with ICON’s tweet aggregator, DIALIVE. https://www.dialive.org/  

June 22, 2017 More Clinical »
Expediting Drug Approval


Expediting Drug Approval

For patients with serious and rare diseases, time is of the essence, and the traditional drug development process may take far too long. To speed innovative new drugs to market, the FDA has established four expedited programs that allow the development process to be compressed and evidence of the drug’s effectiveness gathered as efficiently as […]

April 3, 2017 More Clinical »
Keeping Up with Innovation: Institutional Review Boards and Therapeutic Specialization


Keeping Up with Innovation: Institutional Review Boards and Therapeutic Specialization

The therapeutic landscape is shifting rapidly, and it’s becoming more and more important for those involved in overseeing clinical research to be familiar with the latest breakthroughs and treatments. Increasing sophistication in the design, conduct, and analysis of clinical research complicates the review process, as IRBs must possess the expertise to understand the underlying science […]

July 14, 2017 More Clinical »
FEEDBACK